CJMY
Sunfert International Fertility Centre (Sunfert) has been recognized once again for its exceptional achievements in the field of fertility treatment.
The centre has been awarded the titles of ‘Fertility Centre of The Year in Asia Pacific’ and ‘Excellence in Patient Service Provider of The Year in Asia Pacific’ at the esteemed GlobalHealth Asia-Pacific Awards 2023.
This recognition further solidifies Sunfert’s position as a leading institution in the industry, having successfully helped thousands of couples in their journey towards parenthood.
Sunfert’s commitment to patient service excellence
Sunfert’s patient-centred approach and unwavering commitment to providing outstanding patient service have been key factors in its success.
Lakshmi Menon, General Manager of Sunfert Group, emphasized the importance of prioritizing patient outcomes and understanding the emotional journey couples go through in their pursuit of starting or expanding their families.
Sunfert’s team of experienced fertility specialists, nurses, and support staff work together to create a supportive and empowering environment for their patients, fostering open communication and addressing individual needs and concerns.
The centre’s dedication to safety and quality is reflected in the accreditation of all their branches by the Reproductive Technology Accreditation Committee (RTAC), a professional group under the Board of Fertility Society of Australia.
This accreditation highlights Sunfert’s commitment to patient-centred fertility care and ensures the highest standards throughout the treatment process.
Innovation and Expansion at Sunfert
Sunfert’s journey began in 2009 with a mission to help couples achieve their dreams of parenthood.
Today, they are a comprehensive fertility centre with its own genetic testing laboratory, enabling faster turnaround of results and stringent in-house quality control.
Their flagship centre in Bangsar South, Kuala Lumpur is equipped with state-of-the-art medical technology, including an in-house genetic testing laboratory for precise pre-implantation genetic testing procedures.
Sunfert has expanded its reach with additional branches in Ipoh, Seremban, and Kuching, with plans for further expansion within Malaysia and the Southeast Asian region.
In 2020, Sunfert achieved another significant milestone by establishing Malaysia’s first private Oncofertility hub.
Through the use of innovative technology called Ovarian Tissue Cryopreservation, women and pre-pubertal girls can preserve their ovarian tissues before undergoing cancer treatment.
This procedure safeguards their reproductive potential, allowing them to fulfil their desire for a family when they are ready, even after being cleared of cancer.
Sunfert’s recent accolades highlight not only their success but also Malaysia’s leading position in fertility services in Asia.
The centre’s reputation extends beyond Malaysia, attracting patients from Singapore, Indonesia, Japan, China, Hong Kong, India, Australia, the UK, and other parts of the world.
Sunfert’s commitment to accessibility is evident through various payment options, including the use of EPF Account 2 and the government’s tax relief incentive for fertility treatments.
For more information, visit www.sunfert.com
Admin
